Cost is usually the first practical question families ask once they’ve decided to explore stem cell therapy for a child with cerebral palsy — and it’s a fair one, because packages vary widely and pricing is rarely transparent industry-wide. This guide breaks down what actually drives the price, what published ranges across Indian providers look like, and the questions worth asking before you commit any money.
⚠️ Before the cost breakdown — please read this: Stem cell therapy for cerebral palsy is not currently an FDA-approved or ICMR-recognised standard-of-care treatment anywhere in the world, including India. It remains investigational. Cost should never be the deciding factor in choosing to pursue it — the medical evidence, the clinic’s transparency, and your child’s specific case should come first. We cover this in more detail further down this page.
Quick Answer
Published packages for stem cell treatment for cerebral palsy in India commonly range from roughly $5,000 to $12,000 USD (approximately ₹4 lakh to ₹10 lakh), typically inclusive of stem cell processing, the procedure itself, a hospital stay, and a course of rehabilitation therapy. The exact figure depends heavily on the type and number of cells used, how many sessions are planned, the length of hospital stay, and the accompanying rehabilitation program. Because pricing varies so much between providers, treat any number you see online — including the range above — as a starting reference point, not a quote, and always request a personalised, itemised estimate after your child’s case has been reviewed.
What's Typically Included in a Stem Cell Treatment Package in India?
A comprehensive package generally bundles together several components rather than charging for the injection alone:
- Pre-treatment diagnostics — MRI/imaging review, blood work, and case assessment to confirm candidacy
- Cell procurement and processing — collection and lab preparation of the stem cells (source and method vary by clinic and protocol)
- The procedure itself — administration of the cells, typically via IV infusion and/or intrathecal injection
- Hospital stay — usually 1–3 weeks depending on the protocol
- Rehabilitation therapy — physiotherapy, occupational therapy, and sometimes speech therapy bundled into the stay
- Follow-up consultations — post-treatment review appointments
Packages that quote a much lower figure may be excluding several of these components — which is exactly why an itemised quote matters more than a headline number.
Published Cost Ranges: India vs. Other Countries
| Country | Typical Published Range (USD) | What’s Usually Included |
|---|---|---|
| India | $5,000 – $12,000 | Cell processing, procedure, hospital stay, rehab therapy |
| USA | $25,000 – $50,000 | Procedure only (rehab typically billed separately) |
| UK | $30,000 – $35,000 | Procedure only |
| Mexico | $10,000 – $15,000 | Procedure, limited stay |
| Thailand | $15,000 – $22,000 | Hospital stay, basic therapy |
These figures are drawn from publicly listed prices across multiple providers and medical-tourism platforms as general market reference points — not a quote from any single clinic. Request a personalised, written estimate before making any decision.
What Actually Drives the Price Up or Down?
- Type and source of cells — autologous (the patient’s own, e.g. bone marrow or cord blood if banked) vs. allogeneic (donor-derived) cells carry different processing costs
- Number of doses/sessions — some protocols are single-session, others involve multiple doses spaced over weeks or months
- Route of administration — IV infusion alone is generally less complex (and less costly) than protocols combining IV with intrathecal (spinal) administration
- Length of hospital stay — longer observation and rehab periods add to the total
- Intensity of the rehabilitation program — daily one-on-one physiotherapy/occupational therapy across multiple weeks costs more than a lighter program
- Diagnostics and pre-treatment workup — the thoroughness of case evaluation before treatment is approved
- Clinic accreditation and lab standards — NABH/GMP-certified facilities with rigorous cell-quality testing typically cost more than unaccredited providers, and that’s generally a cost worth paying for safety reasons
Before You Pay: Questions Worth Asking Any Clinic
Because this is an investigational treatment and prices vary so widely, a transparent provider should be able to answer these clearly, not deflect them:
- Is this offered as part of a registered clinical trial, or as a minimally manipulated, same-day autologous procedure? Which regulatory pathway does it fall under?
- Exactly what’s included in the quoted price, and what’s billed separately (medications, extended stay, additional sessions)?
- What accreditation does the facility and lab hold (NABH, ISO, GMP)?
- Can they share realistic, evidence-based expectations — not guaranteed outcomes or specific “success rate” percentages that aren’t backed by published data?
- What is the refund/cancellation policy if your child is assessed as not a suitable candidate after diagnostics?
The Regulatory and Evidence Context (Please Don't Skip This)
Under the ICMR–DBT National Guidelines for Stem Cell Research, reaffirmed by a Supreme Court ruling in January 2026, mesenchymal stem cell therapy is not recognised as standard-of-care for cerebral palsy or other neurological conditions in India — it remains investigational. This mirrors the global regulatory position: no stem cell therapy for cerebral palsy has received approval from the FDA or any equivalent regulator worldwide, despite well over a decade of clinical research. Published clinical studies — including cord-blood research — show some evidence of improved gross motor function in certain patients, but results are described as heterogeneous (inconsistent across studies), and researchers are clear that this is not yet a guaranteed or standardised treatment.
This doesn’t mean the research isn’t worth exploring for the right case — but it does mean cost comparisons should never be separated from this context. A lower price does not make an unproven treatment more proven, and a higher price doesn’t guarantee a better outcome. Decisions should be made with your child’s neurologist involved, alongside — not instead of — established therapies like physiotherapy, occupational therapy, and orthopedic management, which remain the evidence-based foundation of cerebral palsy care.
How This Fits With Other Treatment Options
If you haven’t yet reviewed the broader treatment picture, our main guide on stem cell treatment for cerebral palsy in India covers candidacy, procedure details, and what current research shows. Some families also research exosome therapy for cerebral palsy, a related but distinct regenerative approach with its own separate pricing and protocol. And if you’re trying to understand what recovery and follow-up actually look like once treatment is complete, see life after cerebral palsy stem cell therapy.
Frequently Asked Questions
Published packages across Indian providers commonly range from about $5,000 to $12,000 USD, though the exact figure depends on the cell type, number of sessions, hospital stay, and rehabilitation program included. Request an itemised quote rather than relying on a headline number.
Lower costs largely reflect differences in overall healthcare and labour costs, and Indian packages often bundle in hospital stay and rehabilitation therapy that would be billed separately in the US or UK. It does not necessarily reflect a difference in treatment quality — accreditation and lab standards are what actually indicate quality, not geography.
No. Price reflects the components of the package (cell type, sessions, facility, rehab intensity), not a guaranteed outcome. Given that stem cell therapy for cerebral palsy remains investigational worldwide, no clinic — regardless of price — can ethically guarantee results.
Generally, no. Because it’s classified as investigational rather than standard-of-care, most health insurance policies in India and internationally do not cover it. Confirm directly with your insurer for your specific policy.
Be cautious of clinics quoting unusually low prices with no itemised breakdown, no accreditation details, and no willingness to discuss the regulatory basis of the treatment they’re offering, or those promising specific guaranteed “success rate” percentages — legitimate providers won’t promise a fixed outcome for an investigational therapy.
Related Reading
- Stem Cell Treatment for Cerebral Palsy in India — our main treatment guide
- Exosome Therapy for Cerebral Palsy — a related regenerative option
- Life After Cerebral Palsy Stem Cell Therapy: Recovery — what to expect afterward
- Characteristics of Cerebral Palsy — understanding the condition itself
Disclaimer: This page is for general informational purposes and does not constitute medical or financial advice. Stem cell therapy for cerebral palsy is investigational and not recognised as standard-of-care treatment in India or internationally. Cost figures are drawn from publicly available industry information and are indicative only — always request a personalised, written quotation and consult a qualified paediatric neurologist before making any treatment or payment decision.